Related Experiment Video

Updated: Jul 28, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Physician-prompting statin therapy intervention improves outcomes in patients with coronary heart disease

D E Hilleman1, M S Monaghan, C L Ashby

  • 1School of Pharmacy and Allied Health Professions, Creigton University, Omaha, Nebraska 68178, USA. hilleman@creighton.edu

Pharmacotherapy
|November 21, 2001
PubMed

Insights

A posthospital discharge intervention improved statin use in coronary heart disease patients. This led to better lipid management and significantly reduced cardiovascular events and mortality.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Coronary heart disease (CHD) management requires effective lipid-lowering therapy.
  • Optimal use of statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) is crucial for reducing cardiovascular events in CHD patients.
  • Adherence to treatment guidelines and regular monitoring of lipid profiles are essential for statin effectiveness.

Purpose of the Study:

  • To assess the efficacy of a posthospital discharge intervention aimed at enhancing physician-led statin therapy in patients with coronary heart disease.
  • To determine if prompting physicians improves statin utilization, lipid profile assessment, and achievement of low-density lipid (LDL) cholesterol goals.
  • To evaluate the impact of the intervention on adverse cardiovascular outcomes.

Main Methods:

  • A randomized controlled trial involving 612 patients with CHD admitted to a coronary care unit.
  • An intervention group received physician-prompting via letters or phone calls with patient-specific recommendations for statin therapy and lipid monitoring.
  • A control group received no follow-up intervention. Outcomes were compared over a 2-year period.

Main Results:

  • The intervention group showed significantly higher rates of lipid profile measurement, statin treatment, statin dosage titration, and achievement of NCEP LDL goals compared to the control group.
  • At 2-year follow-up, 72% of the intervention group received statins versus 43% in the control group.
  • Adverse cardiovascular events, including recurrent myocardial infarction, hospitalization for ischemia, revascularization, and cardiovascular mortality, were significantly reduced in the intervention group.

Conclusions:

  • A simple physician-prompting intervention effectively increased statin use and improved lipid management in CHD patients.
  • Enhanced statin therapy significantly reduced adverse cardiovascular outcomes.
  • This intervention strategy should be widely adopted for eligible patient populations to improve cardiovascular health.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...